Better Pharma ETF: iShares IHE vs. State Street XPH
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
This article compares two pharmaceutical ETFs: iShares U.S. Pharmaceuticals ETF (IHE) and State Street SPDR S&P Pharmaceuticals ETF (XPH). It highlights their different approaches to the pharmaceutical industry, with IHE being market-cap weighted and concentrated in large players like Eli Lilly and Johnson & Johnson, while XPH offers broader, more equal-weighted exposure.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.